CLVS Profile

    CLVS trades on the NASDAQ.

    MEMBERSHIP
    --




    DESCRIPTION
    Show Description

    CLVS Earnings


    Q3 Earnings for Jul, Aug & Sep

    Thu, Nov 7, 2019

    Since Earnings Report

    CLVS +148.8%


    Q4 Earnings for Oct, Nov & Dec

    Mon, Feb 24, 2020




    Profile NASDAQ: CLVS $670 Million Small-Cap. Show More


    CLVS Industry Competitors


    BIOTECH & PHARMA
    Johnson & Johnson
    Merck
    Pfizer
    Bristol-Myers Squibb
    Novo Nordisk A/S
    Amgen
    Eli Lilly
    AbbVie
    Sanofi SA (ADR)
    Gilead Sciences

    BIOTECH & PHARMA

    Symbol Surfers Sign In To Access To The TOP 10 PERFORMING DIVIDEND ARISTOCRATS OVER 5 YEAR PERIOD "Video Explainer Transcript". [ Plus Subscription Required ]

    Dividend Aristocrats Sorted By 5 Year Price Change High To Low

    Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

    TOP 10 PERFORMING DIVIDEND ARISTOCRATS OVER 5 YEAR PERIOD

    Free Video Explainer Transcript



    Symbol MC DY Price Day YTD
    CLVS $0.67 0.00% $8.93 -3.0% -12.9%






        TOP    








    info@symbolsurfing.com

    Symbol Surfing

    ©2020 Symbol Surfing All Rights Reserved.

    Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

    Cookies Policy Terms Of Service Privacy Policy